Athersys Inc (ATHXQ)
OTCMKTS: ATHXQ · Delayed Price · USD
0.0044
0.00 (0.00%)
Apr 26, 2024, 3:58 PM EDT - Market closed

Athersys Revenue

Athersys had revenue of $145.00K in the twelve months ending June 30, 2023, down -98.65% year-over-year. Revenue in the quarter ending June 30, 2023 was $49.00K, a -97.88% decrease year-over-year. In the year 2022, Athersys had annual revenue of $5.33M, a decrease of -3.43%.

Revenue (ttm)
$145.00K
Revenue Growth
-98.65%
P/S Ratio
0.63
Revenue / Employee
$6,042
Employees
24
Market Cap
91.08K USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20225.33M-189.00K-3.43%
Dec 31, 20215.51M4.07M282.92%
Dec 31, 20201.44M-4.19M-74.44%
Dec 31, 20195.63M-18.66M-76.81%
Dec 31, 201824.29M20.58M555.10%
Dec 31, 20173.71M-13.64M-78.62%
Dec 31, 201617.35M5.40M45.19%
Dec 31, 201511.95M10.33M636.17%
Dec 31, 20141.62M-815.00K-33.43%
Dec 31, 20132.44M-6.27M-72.00%
Dec 31, 20128.71M-1.64M-15.82%
Dec 31, 201110.34M1.41M15.72%
Dec 31, 20108.94M6.78M314.03%
Dec 31, 20092.16M-946.00K-30.47%
Dec 31, 20083.11M-155.00K-4.75%
Dec 31, 20073.26M-465.00K-12.48%
Dec 31, 20063.73M129.00K3.59%
Dec 31, 20053.60M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 371.62B
Johnson & Johnson 85.16B
Merck & Co. 60.12B
AbbVie 54.32B
Novartis AG 49.92B
AstraZeneca 45.81B
Thermo Fisher 42.86B
Abbott Laboratories 40.11B
Revenue Rankings